Progyny, Inc. (PGNY)

Market Cap	3.02B
Revenue (ttm)	786.91M
Net Income (ttm)	30.36M
Shares Out	93.38M
EPS (ttm)	0.30
PE Ratio	108.17
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	631,456
Open	31.71
Previous Close	31.29
Day's Range	31.12 - 32.69
52-Week Range	25.67 - 53.10
Beta	1.55
Analysts	Buy
Price Target	45.08 (+39.48%)
Earnings Date	May 3, 2023

About PGNY

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimburseme...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Oct 25, 2019
• Employees: 311
• Stock Exchange: NASDAQ
• Ticker Symbol: PGNY

Financial Performance

In 2022, Progyny's revenue was $786.91 million, an increase of 57.19% compared to the previous year's $500.62 million. Earnings were $30.36 million, a decrease of -53.84%.

Analyst Forecast

According to 12 analysts, the average rating for PGNY stock is "Buy." The 12-month stock price forecast is $45.08, which is an increase of 39.48% from the latest price.

Price Target

$45.08

(39.48% upside)

Analyst Consensus: Buy